Efficacy and limitations of a specific immunotherapy in chronic hepatitis B

Journal of Hepatology

Volumn 34, Issue 6, 2001, Pages 917-921

  Pol, Stanislas ^a   Nalpas, Bertrand ^a   Driss, Françoise ^b   Michel, Marie Louise ^c   Tiollais, Pierre ^c   Denis, Jacques ^d   Bréchot, Christian ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b BICÊTRE HOSPITAL   (France)

^c INSTITUT PASTEUR   (France)

^d Service d'Hepato Gastroenterologie   (France)

Author keywords

Chronic hepatitis B; Specific immunotherapy; Vaccine therapy

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; VIRUS DNA;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEPATITIS B; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; VACCINATION; VIREMIA; VIRUS LOAD; VIRUS REPLICATION;

ADULT; DNA, VIRAL; FEMALE; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOTHERAPY, ACTIVE; MALE; MIDDLE AGED; VACCINES, SYNTHETIC; VIRUS REPLICATION;

EID: 0034948510     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(01)00028-9     Document Type: Article

References (21)

1. Clinical aspects of hepatitis B virus infection
2. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children
3. Effect of alpha-interferon in patients with hepatitis B antigen-positive chronic hepatitis B: A meta-analysis
4. A one-year trial of lamivudine for chronic hepatitis B
5. A preliminary trial of lamivudine for chronic hepatitis B infection
6. Lamivudine therapy for chronic hepatitis B: A six-month randomized dose-ranging study
7. Vaccines get a new twist
8. A phase I evaluation of the safety and immunogenicity of immunization with recombinant gp 160 in patients with early human immunodeficiency virus infection
9. Multiepitope vaccines intensively increased levels of antibodies recognizing three neutralizing epitopes on human immunodeficiency virus-1 envelope protein
10. Induction of anti-hepatitis B surface antigen (HBsAg). Antibodies in HBsAg producing transgenic mice: A possible way of circumventing "nonresponse" to HBsAg
11. Vaccine therapy for hepatitis B virus (HBV)-carriers: A study in murine HBV-carriers on dose, duration and prognosis
12. Therapeutic vaccination of woodchucks against chronic woodchuck hepatitis virus infection
13. Specific vaccine therapy in chronic, hepatitis B infection
14. Hepatitis B vaccine and anti-HBs complex as approach for vaccine therapy
15. Which patients with chronic hepatitis B virus infection will respond to alpha interferon therapy? A statistical analysis of predictive factors
16. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection
17. Specific vaccine therapy in chronic hepatitis B: Induction of T cell proliferative responses specific for envelope antigens
18. A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus
19. Immunotherapy of chronic hepatitis B in Asian patients using a novel triple antigen hepatitis B vaccine (Hepacare)
20. Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein
21. Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection